Omar Eton
Impact in
- Oncology top 1%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 35
- Cutaneous Melanoma Detection and Management 11
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 8
- Cancer Treatment and Pharmacology 4
-
- Melanoma and MAPK Pathways 12
- Co-authors
- Carl Plager (20 shared papers)Agop Y. Bedikian (26 shared papers)Antônio C. Buzaid (21 shared papers)Sigrid Ring (10 shared papers)Sewa S. Legha (18 shared papers)S S Legha (7 shared papers)Robert S. Benjamin (10 shared papers)Nicholas E. Papadopoulos (9 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Melanoma Research (11 papers)Cancer (9 papers)Journal of Cutaneous Pathology (2 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesBrazilAustralia
In The Last Decade
Omar Eton
69 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 89
- Oncology 1.7k
- Immunology 744
- Molecular Biology 1.1k
- Immunology and Allergy 73
- Ophthalmology 104
Countries citing papers authored by Omar Eton
This map shows the geographic impact of Omar Eton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Eton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Eton more than expected).
Fields of papers citing papers by Omar Eton
This network shows the impact of papers produced by Omar Eton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Eton. The network helps show where Omar Eton may publish in the future.
Co-authors
The 25 scholars most cited alongside Omar Eton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 282 | |
| 2 | 1997 | 239 | |
| 3 | 1998 | 234 | |
| 4 | 2006 | 215 | |
| 5 | 1998 | 178 | |
| 6 | 1996 | 145 | |
| 7 | 2003 | 90 | |
| 8 | 2010 | 76 | |
| 9 | 1995 | 75 | |
| 10 | 2010 | 69 | |
| 11 | 1998 | 67 | |
| 12 | 2004 | 66 | |
| 13 | 2003 | 59 | |
| 14 | 2012 | 58 | |
| 15 | Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience. | 1997 | 57 |
| 16 | 1996 | 54 | |
| 17 | 2009 | 53 | |
| 18 | 2004 | 49 | |
| 19 | 2004 | 46 | |
| 20 | 1999 | 44 |
About Omar Eton
Omar Eton is a scholar working on Oncology, Molecular Biology, Immunology, Hematology and Cell Biology, having authored 70 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Melanoma and MAPK Pathways (12 papers), Cutaneous Melanoma Detection and Management (11 papers), CAR-T cell therapy research (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Microtubule and mitosis dynamics (7 papers), Multiple Myeloma Research and Treatments (7 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (1.7k citations), Immunology (744 citations), Molecular Biology (1.1k citations), Immunology and Allergy (73 citations) and Ophthalmology (104 citations). Omar Eton has collaborated with scholars based in United States, Brazil and Australia. Frequent co-authors include Carl Plager, Agop Y. Bedikian, Antônio C. Buzaid, Sigrid Ring, Sewa S. Legha, S S Legha, Robert S. Benjamin, Nicholas E. Papadopoulos, Nickolas Papadopoulos and A. Y. Bedikian. Their work appears in journals such as Journal of Clinical Oncology, Melanoma Research, Cancer, Journal of Cutaneous Pathology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.